Skip to main content
Clinical Trials/JPRN-UMIN000046570
JPRN-UMIN000046570
Completed
未知

Effects of consumption of the test food on bone density in healthy Japanese menopause women: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of consumption of the test food on bone density in healthy Japanese menopause women

ORTHOMEDICO Inc.0 sites36 target enrollmentSeptember 30, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ORTHOMEDICO Inc.
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2023
End Date
October 2, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are osteoporosis (YAM score of total amount of lumbar vertebra is less than 70%) 2\. Subjects who have taken medications for osteoporosis 3\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 4\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 5\. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 6\. Subjects who receive hormonal therapy 7\. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 8\. Subjects who take supplements, "Foods for Specified Health Uses", "Foods with Functional Claims", or "Food with Nutrient Function Claims" which may influence bone metabolism such as calcium, vitamin D or K, magnesium, lactic acid bacteria, or isoflavones (including daidzein, genistein, or equol) in daily use 9\. Subjects currently taking medicines (include herbal medicines) and supplements 10\. Subjects who are allergic to medications and/or the test\-food\-related products 11\. Subjects who suffer from COVID\-19 12\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 13\. Subjects who are judged as ineligible to participate in the study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials